MrIC, a Novel α-Conotoxin Agonist in the Presence of PNU at Endogenous α7 Nicotinic Acetylcholine Receptors
Aihua Jin(The University of Queensland), Richard J. Lewis(AstraZeneca (Netherlands)), MacDonald J. Christie(The University of Sydney), Sébastien Dutertre(École Nationale Supérieure de Chimie de Montpellier), Paul F. Alewood(The University of Queensland), Nikita Abraham(The University of Queensland), Nayara Braga Emídio(The University of Queensland), Irina Vetter(Centre National de la Recherche Scientifique), Swetha Murali(The University of Sydney), Marco Inserra(The University of Queensland)
Cited by 31
Related Papers
A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases
|Nature Medicine|2015|2.8k
Methods Used to Evaluate Pain Behaviors in Rodents
|Frontiers in Molecular Neuroscience|2017|1.3k
Cloning and expression of a rat D2 dopamine receptor cDNA
|Nature|1988|1.1k
Therapeutic potential of venom peptides
|Nature Reviews Drug Discovery|2003|786
Pathophysiology of Chemotherapy-Induced Peripheral Neuropathy
|Frontiers in Molecular Neuroscience|2017|654